SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Technology StocksVarian Associates (VAR)


Previous 10 Next 10 
From: JakeStraw4/20/2009 8:55:27 AM
   of 203
 
Options Radar Signaling Big Bounce in Two Medical Equipment Makers
seekingalpha.com

Share RecommendKeepReplyMark as Last Read


From: JakeStraw4/29/2009 4:09:32 PM
   of 203
 
Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2009
finance.yahoo.com

Share RecommendKeepReplyMark as Last Read


From: JakeStraw6/17/2009 2:28:42 PM
   of 203
 
Leading Healthcare Group Selects Varian Medical Systems to Supply Cancer Treatment Technology for Treatment Centers Across the Western United States
finance.yahoo.com
Wednesday June 17, 2009, 1:58 pm EDT

Providence Health and Services (PH&S) Enters into Three-Year Agreement with Varian

PALO ALTO, Calif., June 17 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) and Providence Health and Services (PH&S) have signed a three-year agreement for Varian to provide PH&S treatment centers with advanced radiotherapy technology for treating cancer. The agreement covers Varian's state-of-the-art equipment and software.

"The Providence Health & Services organization encompasses over 33 participating treatment facilities across Alaska, Washington, Montana, Oregon, and California," said Michael Oswald, Director of Capital Equipment Contracting at PH&S. "We elected not to renew our previous agreements with certain other cancer treatment technology suppliers, and selected Varian as our vendor for radiation therapy treatment technology going forward."

Share RecommendKeepReplyMark as Last Read


From: JakeStraw6/25/2009 8:48:34 AM
   of 203
 
Varian Medical Systems Acquires Assets of IKOEmed and IKOEtech; Acquisition to Add Software for Accelerating Radiotherapy Treatment Planning
finance.yahoo.com
Thursday June 25, 2009, 8:30 am EDT

The software is designed to achieve greater than 50 percent reduction in the contouring portion of the radiotherapy treatment planning process, which typically takes anywhere from 30 minutes to 4 hours. It automates the contouring process by matching patient images with pre-contoured images from an expert database created by renowned radiation oncologists. This eliminates the need for clinicians to manually outline between 10 and 20 organs in each of anywhere from 100 to 200 images of a patient's disease site.

Share RecommendKeepReplyMark as Last Read


From: JakeStraw7/21/2009 8:31:37 AM
   of 203
 
Varian Medical Systems Receives 510(k) Clearance for Fast and Accurate Acuros(TM) Radiotherapy Treatment Planning Capability
finance.yahoo.com

Share RecommendKeepReplyMark as Last Read


From: JakeStraw7/24/2009 8:40:28 AM
   of 203
 
Varian Medical Systems to Showcase a Wide Spectrum of New and Updated Products That Improve Radiotherapy Treatment Processes at 2009 AAPM Meeting
finance.yahoo.com
Thursday July 23, 2009, 4:19 pm EDT

New version of Eclipse(TM) treatment planning system incorporates five new tools that speed up and enhance radiotherapy treatment planning

Share RecommendKeepReplyMark as Last Read


From: JakeStraw10/28/2009 8:50:02 AM
   of 203
 
Varian Medical Systems to Exhibit a Wide Selection of Flat Panel X-Ray Image Detectors and X-Ray Tubes at the CMEF Show in Chengdu, China
finance.yahoo.com
Wednesday October 28, 2009

Share RecommendKeepReplyMark as Last Read


From: JakeStraw10/30/2009 9:12:48 AM
   of 203
 
Varian Medical 4Q profit rises on system sales
finance.yahoo.com

The company earned $97 million, or 77 cents per share, up from profit of $78.5 million, or 62 cents per share, during the same period a year ago. Revenue rose 8 percent to $642 million from $592.7 million. The fiscal 2009 fourth-quarter ended Sept. 30.

Looking ahead, the company said it expects profit from continuing operations between $2.65 and $2.75 per share in fiscal 2010

Share RecommendKeepReplyMark as Last Read


From: JakeStraw12/4/2009 10:23:42 AM
   of 203
 
Experts eye Varian Medical
thestockadvisors.com

Share RecommendKeepReplyMark as Last Read


From: JakeStraw1/12/2010 8:16:40 AM
   of 203
 
UK Cancer Network Implements Varian's ARIA(TM) for Electronic Prescribing and Comprehensive Electronic Patient Records
finance.yahoo.com

OXFORD, England, Jan. 12 /PRNewswire-FirstCall/ -- A chemotherapy software solution that enables patients to become more involved in managing their own care has been successfully rolled out across a network of hospitals in the UK. The Thames Valley Cancer Network has implemented Aria for Medical Oncology™ from Varian Medical Systems (NYSE: VAR) and already has more than 850 clinical staff routinely using the system.

"The ARIA system has been extremely well received by clinical teams and patients alike," says Dr. Claire Blesing, consultant clinical oncologist at Churchill Hospital in Oxford and clinical lead for the project. "A big plus is that ARIA is not just a prescribing system, like the previous method we had here in Oxford, it's a full medical record. We were looking for something fresh and new to use in trusts that had no great background in electronic chemotherapy prescribing and ARIA gives us all the functionality we require."

Share RecommendKeepReplyMark as Last Read
Previous 10 Next 10